Ascendis Pharma AS (A71) — Strategic Asset Allocation Index
Ascendis Pharma AS (A71) has a Strategic Asset Allocation Index of 4.8% as of March 2026. Strategic assets (PP&E of €- plus long-term investments of €23.56 Million) total €23.56 Million, measured against net assets of €487.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check A71 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ascendis Pharma AS Strategic Asset Allocation Index (2016–2022)
This chart shows how Ascendis Pharma AS's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of March 2026, the index stands at 4.8%, representing strategic assets of €23.56 Million against net assets of €487.97 Million EUR. See A71 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ascendis Pharma AS (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ascendis Pharma AS from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Ascendis Pharma AS worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.6% | €30.42 Million | €- | €30.42 Million | €263.35 Million | ▼ -19.2 pp |
| 2021 | 30.8% | €271.95 Million | €126.05 Million | €145.91 Million | €883.63 Million | ▲ +3.0 pp |
| 2020 | 27.7% | €232.57 Million | €108.11 Million | €124.46 Million | €838.71 Million | ▲ +17.6 pp |
| 2019 | 10.1% | €60.61 Million | €45.07 Million | €15.54 Million | €597.11 Million | ▲ +2.5 pp |
| 2018 | 7.6% | €21.41 Million | €4.33 Million | €17.08 Million | €280.05 Million | ▲ +6.3 pp |
| 2017 | 1.4% | €2.56 Million | €2.56 Million | €0.00 | €187.21 Million | ▲ +0.0 pp |
| 2016 | 1.3% | €2.35 Million | €2.35 Million | €- | €176.61 Million | — |